France The top ten pharma companies in France for 2021. Sanofi leads the pack with EUR 2.367 billion in turnover, followed by Servier (EUR 2.284 billion) and Janssen (EUR 1.175 billion).

Europe Drawing from the 2021 edition of the EFPIA’s comprehensive annual data review of the European pharma industry, we present the Top 5 countries across a variety of pharma metrics: from market size to R&D spend, production, exports, imports, and generics penetration.   Made with Visme Infographic Maker   Made with…

France The Top 10 pharma companies in the EUR 28.9 million French pharma market in 2019. Homegrown players Sanofi and Servier lead the way, followed by Bayer, Janssen and Mylan. French firms Pierre Fabre, Merial and Ceva Sante also make the list, while AstraZeneca and Teva round out the Top 10.…

Facts A snapshot of the latest data on the French pharmaceutical industry from industry association LEEM, including market revenues, R&D investments, employment and consumption. Made with Visme Presentation Maker

France The Top 20 pharma companies in France, ranked by total turnover at ex-manufacturer prices for 2018. Swiss giant Novartis is in first place with a EUR 2.6 billion turnover, a full 89 percent of which came from the retail market. In second place is local champion Sanofi with a turnover…

France Key statistics on the workforce, revenue, investment levels, R&D spending and consumption in the French pharmaceutical industry today. Mapping the 32 biopharma production sites in France, including the location, company and products produced. France ranks fourth in the EU for pharma production with EUR 20.981 billion in value, behind Switzerland,…

Top 20 Pharma Companies in France The following chart shows the top 20 pharma companies in France, ranked by sales for the year 2015. Global giant Novartis leads the way, followed by national champion Sanofi, and American titan Pfizer. French Pharma Map This map shows the overall contribution of the…

Pharma This map shows the overall contribution of the pharmaceutical industry to the French economy, including number of employees by region, investment stats, and information on private sector research. Click here to download the latest free pharma report on France.

Health The chart below illustrates the potential for a shift in healthcare provision towards home care in France; a country with a rapidly increasing over 60 population, an expensive nursing home system, and a culture of living at home into old age. Click here to download the latest free pharma report on…

Pharma The following chart illustrates the various bottlenecks restraining the development of France’s pharmaceutical industry, including lack of investment, fewer new molecules than other European countries, disappointing performance in biological drugs, and long waiting times for drug approval. Click here to read more articles and interviews from France, and to download the…

Pharma The following chart shows the top 20 pharma companies in France, ranked by sales for the year 2015. Global giant Novartis leads the way, followed by national champion Sanofi, and American titan Pfizer. Click here to read more articles and interviews from France, and to download the latest free pharma…

France France spends 11.6% of its GDP on health. This is behind the USA (17.1%) but ahead of Germany (11.2%), Japan (10.2%), Denmark (11.2%), and the united Kingdom (8.8%). The growth in healthcare spending as a share of GDP that occurred in 2009 across all of these countries can be attributed chiefly…